Mide Kanseri Ve Kemoterapisinde Yenilikler
作者： Handan Karaoğuz
DOI:
关键词:
摘要: M i d e kanse r t u m n y a oneml bir sagl ik p rob l o s k . A B D v (A .B .D) ve ge ismis bati lke lerde g iderek z egi imi gos te rmek le birl ikte, lumler in ilk sek ic inde yer lmak tad (1). ' 1990 yili istatistik ler ine go re rkek rde ran % 2 6 7 , kad la rda se 1 9 (2). G ins idans 3 : 0 inmist ke de b rmetued karsi J Şi bazi K lkeler ta lya esk S Birl igi gibi ns ha len ldukca yuksek lup 8 'de ra c ikmak (1,3).
参考文章(30)
S.-I. Abe, M. Shiraishi, H. Yoshimura, S. Nagaoka, T. Nakamura, Dipok Kumar Dhar, Serosal invasion as the single prognostic indicator in stage IIIA (T3N1M0) gastric cancer. Surgery. ,vol. 109, pp. 582- 588 ,(1991)
WilliamH. Allum, MichaelT. Hallissey, KrystynaA. Kelly, British Stomach Cancer Group, ADJUVANT CHEMOTHERAPY IN OPERABLE GASTRIC CANCER: 5 Year Follow-up of First British Stomach Cancer Group Trial The Lancet. ,vol. 333, pp. 571- 574 ,(1989) , 10.1016/S0140-6736(89)91607-3
P Preusser, H Wilke, W Achterrath, U Fink, L Lenaz, A Heinicke, J Meyer, H J Meyer, H Buente, Phase II study with the combination etoposide, doxorubicin, and cisplatin in advanced measurable gastric cancer. Journal of Clinical Oncology. ,vol. 7, pp. 1310- 1317 ,(1989) , 10.1200/JCO.1989.7.9.1310
Yoshihiko Maehara, Sunao Moriguchi, Yoshihisa Sakaguchi, Yasunori Emi, Shunji Kohnoe, Shunichi Tsujitani, Keizo Sugimachi, Adjuvant chemotherapy enhances long-term survival of patients with advanced gastric cancer following curative resection. Journal of Surgical Oncology. ,vol. 45, pp. 169- 172 ,(1990) , 10.1002/JSO.2930450307
P. Preusser, W. Achterrath, H. Wilke, L. Lenaz, U. Fink, A. Heinicke, J. Meyer, H. Bunte, Chemotherapy of gastric cancer Cancer Treatment Reviews. ,vol. 15, pp. 257- 277 ,(1988) , 10.1016/0305-7372(88)90025-4
JafferA. Ajani, Pamela Goudeau, Bernard Levin, JackS. Faintuch, JamesL. Abbruzzese, BruceM. Boman, MaheshD. Kanojia, Phase II study of adriamycin with sequential methotrexate and 5-fluorouracil (AMF) in gastric carcinoma. Cancer Chemotherapy and Pharmacology. ,vol. 24, pp. 41- 44 ,(1989) , 10.1007/BF00254103
Daisuke Korenaga, Hideo Baba, Akihiro Watanabe, Masaru Haraguchi, Yoshihiro Kakeji, Hiroyuki Orita, Yoshihiko Maehara, Keizo Sugimachi, None, Adjuvant mitomycin-C prolongs survival time of patients undergoing extensive en bloc resection of carcinoma of the stomach invading the adjacent organs. Pharmacology. ,vol. 41, pp. 107- 112 ,(1990) , 10.1159/000138705
J. Wils, H. Bleiberg, Current status of chemotherapy for gastric cancer. European Journal of Cancer and Clinical Oncology. ,vol. 25, pp. 3- 8 ,(1989) , 10.1016/0277-5379(89)90043-6
D Cunningham, Gastric cancer – the recognition of a chemosensitive tumour British Journal of Cancer. ,vol. 58, pp. 695- 699 ,(1988) , 10.1038/BJC.1988.292
Massimo Lopez, Luigi Di Lauro, Paola Papaldo, Ettore M.S. Conti, Treatment of advanced measurable gastric carcinoma with 5-fluorouracil, adriamycin, and BCNU Oncology. ,vol. 43, pp. 288- 291 ,(1986) , 10.1159/000226384